BioRem Statistics

Total Valuation

BioRem has a market cap or net worth of 25.31 million. The enterprise value is 20.73 million.

Market Cap	25.31M
Enterprise Value	20.73M

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	15.70M
Shares Outstanding	n/a
Shares Change (YoY)	+1.38%
Shares Change (QoQ)	+18.67%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	15.38M

Valuation Ratios

The trailing PE ratio is 13.29.

PE Ratio	13.29
Forward PE	n/a
PS Ratio	1.00
PB Ratio	3.40
P/TBV Ratio	3.40
P/FCF Ratio	8.87
P/OCF Ratio	8.66
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.34, with an EV/FCF ratio of 7.26.

EV / Earnings	10.89
EV / Sales	0.78
EV / EBITDA	6.34
EV / EBIT	7.21
EV / FCF	7.26

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.32.

Current Ratio	1.65
Quick Ratio	1.29
Debt / Equity	0.32
Debt / EBITDA	0.76
Debt / FCF	0.82
Interest Coverage	20.84

Financial Efficiency

Return on equity (ROE) is 30.30% and return on invested capital (ROIC) is 19.17%.

Return on Equity (ROE)	30.30%
Return on Assets (ROA)	9.72%
Return on Invested Capital (ROIC)	19.17%
Return on Capital Employed (ROCE)	29.17%
Revenue Per Employee	741,386
Profits Per Employee	56,002
Employee Count	34
Asset Turnover	1.44
Inventory Turnover	11.95

Taxes

In the past 12 months, BioRem has paid 693,813 in taxes.

Income Tax	693,813
Effective Tax Rate	26.71%

Stock Price Statistics

The stock price has increased by +13.69% in the last 52 weeks. The beta is 0.76, so BioRem's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+13.69%
50-Day Moving Average	1.43
200-Day Moving Average	1.80
Relative Strength Index (RSI)	63.44
Average Volume (20 Days)	2,849

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioRem had revenue of 25.21 million and earned 1.90 million in profits. Earnings per share was 0.09.

Revenue	25.21M
Gross Profit	6.53M
Operating Income	2.72M
Pretax Income	2.60M
Net Income	1.90M
EBITDA	2.96M
EBIT	2.72M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 6.68 million in cash and 2.34 million in debt, giving a net cash position of 4.33 million.

Cash & Cash Equivalents	6.68M
Total Debt	2.34M
Net Cash	4.33M
Net Cash Per Share	n/a
Equity (Book Value)	7.44M
Book Value Per Share	0.47
Working Capital	6.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.92 million and capital expenditures -69,383, giving a free cash flow of 2.85 million.

Operating Cash Flow	2.92M
Capital Expenditures	-69,383
Free Cash Flow	2.85M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 25.91%, with operating and profit margins of 10.78% and 7.55%.

Gross Margin	25.91%
Operating Margin	10.78%
Pretax Margin	10.31%
Profit Margin	7.55%
EBITDA Margin	11.72%
EBIT Margin	10.78%
FCF Margin	11.32%

Dividends & Yields

BioRem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.38%
Shareholder Yield	n/a
Earnings Yield	7.52%
FCF Yield	11.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioRem has an Altman Z-Score of 3.53 and a Piotroski F-Score of 7.

Altman Z-Score	3.53
Piotroski F-Score	7